Calculating the Expected Net Benefit of Sampling for Survival Data: A Tutorial and Case Study

Mathyn Vervaart

Medical Decision Making, 2024, vol. 44, issue 7, 719-741

Abstract: The net value of reducing decision uncertainty through collecting additional data is quantified by the expected net benefit of sampling (ENBS). The ENBS is the difference between the population-level expected value of sample information (EVSI) for the data collection exercise and the costs associated with the data collection. ENBS calculations for studies that collect survival data are complicated by the need to take into account censoring, and this has limited the application of value-of-information analysis in this setting. In this tutorial article, we present a general-purpose algorithm for calculating the ENBS for a study that collects survival data along with a step-by-step implementation in R. The algorithm is based on recently published methods for simulating survival data and computing EVSI that do not rely on the survival data being from a distribution with any particular parametric form and that can take into account any arbitrary censoring process. We illustrate the method using a real-life case study drawn from an appraisal of pembrolizumab plus axitinib for treating advanced renal cell carcinoma in which the initial decision was informed by immature survival data. Highlights The net value of reducing decision uncertainty by collecting additional data is quantified by the expected net benefit of sampling (ENBS). This tutorial presents a general-purpose algorithm for computing the ENBS for collecting survival data along with a step-by-step implementation in R. The algorithm is based on recently published methods for simulating survival data and computing expected value of sample information that do not rely on the survival data to follow any particular parametric distribution and that can take into account any arbitrary censoring process. We demonstrate in a case study based on a previous cancer technology appraisal that ENBS calculations are useful not only for designing new studies but also for optimizing reimbursement decisions for new health technologies based on immature evidence from ongoing trials.

Keywords: expected value of sample information; expected net benefit of sampling; survival data; simulation methods; economic evaluation model; value of information (search for similar items in EconPapers)
Date: 2024
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/0272989X241279459 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:medema:v:44:y:2024:i:7:p:719-741

DOI: 10.1177/0272989X241279459

Access Statistics for this article

More articles in Medical Decision Making
Bibliographic data for series maintained by SAGE Publications ().